Narendra Nagpure

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Beyond Antibodies: Glypican‐3‐Targeting Peptides for Precision Hepatocellular Carcinoma Theranostics
  Journal of Peptide Science 2026 DOI: 10.1002/psc.70134
  +Save
• Optimizing the Cardiotoxicity Profile of Osimertinib via Scaffold Hopping: An Integrated Cheminformatics and Molecular Modeling Approach
  Narendra R. Nagpure, Vaibhav Kadam, Bhatu R. Patil +4 more
  Journal of Computational Biophysics and Chemistry 2026 DOI: 10.1142/S2737416526500754
  +Save
• Lazertinib: A Cardio‐Safer Alternative to Osimertinib for Epidermal Growth Factor Receptor L858R/T790M Double‐Mutant Tyrosine Kinase Resistant Non‐Small Cell Lung Cancer
  Drug Development Research 2025 DOI: 10.1002/ddr.70153
  +Save
• Overcoming triple mutant EGFR-tyrosine kinase barriers in the therapeutics of non-small cell lung cancer: a patent review on fourth-generation inhibitors (2017-2024)
  Expert Opinion on Therapeutic Patents 2025 DOI: 10.1080/13543776.2025.2536006
  +Save
• Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis
  Lung Cancer 2025 DOI: 10.1016/j.lungcan.2025.108629
  +Save
• In silico, in vitro, and in vivo assessment of chitosan-diltiazem nanoparticles against pulmonary fibrosis
  Nandeeni Punase, Ganesh V. Jamdar, Ghanshyam Mapare +5 more
  Therapeutic Delivery 2025 DOI: 10.1080/20415990.2025.2478803
  +Save
• Exploring Cannabidiol–TRPV3 Mediated Biological Activities—Findings From Molecular Docking, Simulation and Proteins Network Interactions
  Jagdish Chand, Narendra R. Nagpure, Gupta Dheeraj Rajesh +6 more
  Chemistry & Biodiversity 2025 DOI: 10.1002/cbdv.202403494
  +Save